Wockhardt US unit gets FDA warning notePost published:March 1, 2017Post category:Industry NewsProducts of Wockhardt’s US unit Morton Grove Pharma will be available in that market but new approvals will be withheld until compliance issues are resolved Source: Livemint.com (http://www.livemint.com/rss/industry)Read more articles Previous PostMasterCard eyes 1 million traders on its BharatQR platform Next PostYahoo chief counsel exits after hack probe finds inaction You Might Also Like Offline Robot Programming Without Picking Up a Teach Pendant May 6, 2019 RBI to sell sovereign bonds worth Rs10,000 crore via open market operations September 30, 2017 Eaton introduces XV100 HMI, XV300 HMI and XP500 industrial PC February 8, 2018